Maximus (MMS)
(Delayed Data from NYSE)
$91.38 USD
+0.10 (0.11%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $90.74 -0.64 (-0.70%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$91.38 USD
+0.10 (0.11%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $90.74 -0.64 (-0.70%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Zacks News
ICF International (ICFI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ICF (ICFI) delivered earnings and revenue surprises of 11.18% and 0.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Booz Allen Hamilton (BAH) Misses Q1 Earnings Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of -9.21% and 0.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) Surges 11% in 3 Months: Should You Buy the Stock?
by Shuvra Shankar Dey
Maximus' (MMS) long-term growth potential remains strong, making it a compelling stock to watch for the right investment opportunity.
Strength Seen in ICF (ICFI): Can Its 3.6% Jump Turn into More Strength?
by Zacks Equity Research
ICF (ICFI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks.com featured highlights include Amkor Technology, Tenet Healthcare, Leidos and Maximus
by Zacks Equity Research
Amkor Technology, Tenet Healthcare, Leidos and Maximus are part of the Zacks Screen of the Week article.
4 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like AMKR, THC, LDOS and MMS that are seeing price strength have a high chance of carrying the momentum forward.
Here's Why Maximus (MMS) is an Attractive Pick Right Now
by Zacks Equity Research
Commitment to shareholder returns makes Maximus (MMS) a reliable way for investors to compound wealth over the long term.
Is Maximus (MMS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Stocks Trading Near 52-Week High With More Upside Potential
by Vasundhara Sawalka
Investors target stocks that have lately been on a bull run. Stocks like LPX, MMS, THC and AMKR are seeing price strength and have a high chance of carrying the momentum forward.
Maximus (MMS) Up 2.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Maximus and Diodes have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Maximus and Diodes are part of the Zacks Bull and Bear of the Day article.
Bull of the Day: Maximus (MMS)
by Shaun Pruitt
Benefiting from a strong business industry, it's hard to overlook the very favorable trading indicators for Maximus (MMS) stock with MMS commanding an overall "A" VGM Zacks Style Scores Grade for the combination of Value, Growth, and Momentum.
Maximus (MMS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for May 30th
by Zacks Equity Research
IHG, MMS and GOLD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 30, 2023.
Best Value Stocks to Buy for May 30th
by Zacks Equity Research
AGRO, COOP and MMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 30, 2023.
Should Value Investors Buy Maximus (MMS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Booz Allen (BAH) Earnings & Revenues Beat Estimates in Q4
by Zacks Equity Research
Booz Allen's (BAH) Q4 earnings and revenues increase year over year.
Here's Why Maximus (MMS) is an Attractive Pick Right Now
by Zacks Equity Research
Long-term contracts provide Maximus (MMS) with a steady flow of revenues.
Maximus (MMS) Stock Gains 3% Since Q2 Earnings Beat Estimates
by Zacks Equity Research
Maximus' (MMS) second-quarter fiscal 2024 earnings and revenues increase on a year-over-year basis.
Are Investors Undervaluing Maximus (MMS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Stocks to Buy After Posting Strong EPS Growth
by Shaun Pruitt
Several stocks from a variety of sectors are starting to stand out after posting strong EPS growth for the quarter and beating earnings expectations on Wednesday.
Maximus (MMS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Maximus (MMS) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Maximus (MMS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 19.85% and 5.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Pagaya (PGY) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Pagaya (PGY) is likely to have witnessed top and bottom-line growth in first-quarter 2024.
Gear Up for Maximus (MMS) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Maximus (MMS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.